{"id":68936,"date":"2024-08-09T10:06:03","date_gmt":"2024-08-09T08:06:03","guid":{"rendered":"https:\/\/www.ipsen.com\/lay-language\/une-etude-sur-lefficacite-du-traitement-pour-les-patients-atteints-de-tumeurs-neuroendocrines-non-fonctionnelles-du-pancreas-de-lintestin-ou-dorigine-inconnue\/"},"modified":"2024-10-06T17:32:21","modified_gmt":"2024-10-06T15:32:21","slug":"une-etude-sur-lefficacite-du-traitement-pour-les-patients-atteints-de-tumeurs-neuroendocrines-non-fonctionnelles-du-pancreas-de-lintestin-ou-dorigine-inconnue","status":"publish","type":"lay_language","link":"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-lefficacite-du-traitement-pour-les-patients-atteints-de-tumeurs-neuroendocrines-non-fonctionnelles-du-pancreas-de-lintestin-ou-dorigine-inconnue\/","title":{"rendered":"Une \u00e9tude sur l’efficacit\u00e9 du traitement pour les patients atteints de tumeurs neuroendocrines non fonctionnelles du pancr\u00e9as, de l’intestin ou d’origine inconnue."},"content":{"rendered":"\n

Somatuline autogel (lanreotide autogel)<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":11,"template":"","lay_language_category":[70159],"class_list":["post-68936","lay_language","type-lay_language","status-publish","has-post-thumbnail","hentry","entry"],"acf":[],"yoast_head":"\nUne \u00e9tude sur l'efficacit\u00e9 du traitement pour les patients atteints de tumeurs neuroendocrines non fonctionnelles du pancr\u00e9as, de l'intestin ou d'origine inconnue. - Global<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-lefficacite-du-traitement-pour-les-patients-atteints-de-tumeurs-neuroendocrines-non-fonctionnelles-du-pancreas-de-lintestin-ou-dorigine-inconnue\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Une \u00e9tude sur l'efficacit\u00e9 du traitement pour les patients atteints de tumeurs neuroendocrines non fonctionnelles du pancr\u00e9as, de l'intestin ou d'origine inconnue. - Global\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-lefficacite-du-traitement-pour-les-patients-atteints-de-tumeurs-neuroendocrines-non-fonctionnelles-du-pancreas-de-lintestin-ou-dorigine-inconnue\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-06T15:32:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/08\/26173609\/Image1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1949\" \/>\n\t<meta property=\"og:image:height\" content=\"1118\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-lefficacite-du-traitement-pour-les-patients-atteints-de-tumeurs-neuroendocrines-non-fonctionnelles-du-pancreas-de-lintestin-ou-dorigine-inconnue\/\",\"url\":\"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-lefficacite-du-traitement-pour-les-patients-atteints-de-tumeurs-neuroendocrines-non-fonctionnelles-du-pancreas-de-lintestin-ou-dorigine-inconnue\/\",\"name\":\"Une \u00e9tude sur l'efficacit\u00e9 du traitement pour les patients atteints de tumeurs neuroendocrines non fonctionnelles du pancr\u00e9as, de l'intestin ou d'origine inconnue. - Global\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-lefficacite-du-traitement-pour-les-patients-atteints-de-tumeurs-neuroendocrines-non-fonctionnelles-du-pancreas-de-lintestin-ou-dorigine-inconnue\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-lefficacite-du-traitement-pour-les-patients-atteints-de-tumeurs-neuroendocrines-non-fonctionnelles-du-pancreas-de-lintestin-ou-dorigine-inconnue\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/08\/26173609\/Image1.png\",\"datePublished\":\"2024-08-09T08:06:03+00:00\",\"dateModified\":\"2024-10-06T15:32:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-lefficacite-du-traitement-pour-les-patients-atteints-de-tumeurs-neuroendocrines-non-fonctionnelles-du-pancreas-de-lintestin-ou-dorigine-inconnue\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-lefficacite-du-traitement-pour-les-patients-atteints-de-tumeurs-neuroendocrines-non-fonctionnelles-du-pancreas-de-lintestin-ou-dorigine-inconnue\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-lefficacite-du-traitement-pour-les-patients-atteints-de-tumeurs-neuroendocrines-non-fonctionnelles-du-pancreas-de-lintestin-ou-dorigine-inconnue\/#primaryimage\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/08\/26173609\/Image1.png\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/08\/26173609\/Image1.png\",\"width\":1949,\"height\":1118},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-lefficacite-du-traitement-pour-les-patients-atteints-de-tumeurs-neuroendocrines-non-fonctionnelles-du-pancreas-de-lintestin-ou-dorigine-inconnue\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/fr\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Une \u00e9tude sur l’efficacit\u00e9 du traitement pour les patients atteints de tumeurs neuroendocrines non fonctionnelles du pancr\u00e9as, de l’intestin ou d’origine inconnue.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#website\",\"url\":\"https:\/\/www.ipsen.com\/fr\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\/\/www.ipsen.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Ipsengroup\",\"https:\/\/x.com\/ipsengroup\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Une \u00e9tude sur l'efficacit\u00e9 du traitement pour les patients atteints de tumeurs neuroendocrines non fonctionnelles du pancr\u00e9as, de l'intestin ou d'origine inconnue. - Global","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-lefficacite-du-traitement-pour-les-patients-atteints-de-tumeurs-neuroendocrines-non-fonctionnelles-du-pancreas-de-lintestin-ou-dorigine-inconnue\/","og_locale":"fr_FR","og_type":"article","og_title":"Une \u00e9tude sur l'efficacit\u00e9 du traitement pour les patients atteints de tumeurs neuroendocrines non fonctionnelles du pancr\u00e9as, de l'intestin ou d'origine inconnue. - Global","og_url":"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-lefficacite-du-traitement-pour-les-patients-atteints-de-tumeurs-neuroendocrines-non-fonctionnelles-du-pancreas-de-lintestin-ou-dorigine-inconnue\/","og_site_name":"Global","article_modified_time":"2024-10-06T15:32:21+00:00","og_image":[{"width":1949,"height":1118,"url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/08\/26173609\/Image1.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@ipsengroup","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-lefficacite-du-traitement-pour-les-patients-atteints-de-tumeurs-neuroendocrines-non-fonctionnelles-du-pancreas-de-lintestin-ou-dorigine-inconnue\/","url":"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-lefficacite-du-traitement-pour-les-patients-atteints-de-tumeurs-neuroendocrines-non-fonctionnelles-du-pancreas-de-lintestin-ou-dorigine-inconnue\/","name":"Une \u00e9tude sur l'efficacit\u00e9 du traitement pour les patients atteints de tumeurs neuroendocrines non fonctionnelles du pancr\u00e9as, de l'intestin ou d'origine inconnue. - Global","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-lefficacite-du-traitement-pour-les-patients-atteints-de-tumeurs-neuroendocrines-non-fonctionnelles-du-pancreas-de-lintestin-ou-dorigine-inconnue\/#primaryimage"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-lefficacite-du-traitement-pour-les-patients-atteints-de-tumeurs-neuroendocrines-non-fonctionnelles-du-pancreas-de-lintestin-ou-dorigine-inconnue\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/08\/26173609\/Image1.png","datePublished":"2024-08-09T08:06:03+00:00","dateModified":"2024-10-06T15:32:21+00:00","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-lefficacite-du-traitement-pour-les-patients-atteints-de-tumeurs-neuroendocrines-non-fonctionnelles-du-pancreas-de-lintestin-ou-dorigine-inconnue\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-lefficacite-du-traitement-pour-les-patients-atteints-de-tumeurs-neuroendocrines-non-fonctionnelles-du-pancreas-de-lintestin-ou-dorigine-inconnue\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-lefficacite-du-traitement-pour-les-patients-atteints-de-tumeurs-neuroendocrines-non-fonctionnelles-du-pancreas-de-lintestin-ou-dorigine-inconnue\/#primaryimage","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/08\/26173609\/Image1.png","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/08\/26173609\/Image1.png","width":1949,"height":1118},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-lefficacite-du-traitement-pour-les-patients-atteints-de-tumeurs-neuroendocrines-non-fonctionnelles-du-pancreas-de-lintestin-ou-dorigine-inconnue\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/fr\/home\/"},{"@type":"ListItem","position":2,"name":"Une \u00e9tude sur l’efficacit\u00e9 du traitement pour les patients atteints de tumeurs neuroendocrines non fonctionnelles du pancr\u00e9as, de l’intestin ou d’origine inconnue."}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/fr\/#website","url":"https:\/\/www.ipsen.com\/fr\/","name":"Global","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/fr\/#organization","name":"IPSEN","url":"https:\/\/www.ipsen.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]}]}},"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/lay_language\/68936"}],"collection":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/lay_language"}],"about":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/types\/lay_language"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/users\/11"}],"version-history":[{"count":1,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/lay_language\/68936\/revisions"}],"predecessor-version":[{"id":68937,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/lay_language\/68936\/revisions\/68937"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/media\/68664"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/media?parent=68936"}],"wp:term":[{"taxonomy":"lay_language_category","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/lay_language_category?post=68936"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}